B and T lymphocyte attenuator (BTLA) and PD-1 pathway dual blockade promotes antitumor immune responses by reversing CD8+ T-cell exhaustion in non-small cell lung cancer
Yang Zhang(University of Science and Technology of China), Jianan Huang(Soochow University), Zeyi Liu(Soochow University), Yuanyuan Zeng(Sichuan University), Yang Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Lirong Gao(Chinese Academy of Sciences), Meiqin Su(Fourth People's Hospital of Taiyuan), Qiu‐Xia Qu(Soochow University), Cheng Chen(Soochow University), Chuanyong Mu(Soochow University), Dan Shen(Soochow University), Jingyu Mao(Soochow University)
Cited by 10
Related Papers
The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer
|International Journal of Oncology|2016|385
Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer
|Molecular Cancer|2018|369
PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer
|International Journal of Clinical Oncology|2017|315
JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells
|International Journal of Oncology|2014|314
Halide-Rich Synthesized Cesium Lead Bromide Perovskite Nanocrystals for Light-Emitting Diodes with Improved Performance
|Chemistry of Materials|2017|302